Overview

Multicenter Randomized Prospective Trial Comparing Methotrexate Alone or in Combination With Adalimumab in Early Arthritis

Status:
Unknown status
Trial end date:
2007-03-01
Target enrollment:
0
Participant gender:
All
Summary
Evaluation of two treatment modalities in early potentially severe early arthritis ( Methotrexate alone or in combination with adalimumab)
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Goupe d'Etudes et de Recherche Clinique En Rhumatologie
Treatments:
Adalimumab
Methotrexate
Criteria
Inclusion Criteria:

- Early Active Potentially severe arthritis

Exclusion Criteria:

- contra indication of methotrexate or anti TNF